Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/24 18:53 | 10/15/24 | HALO | Health | BioPrd | Biological Products, (No Diag | Labarre Michael J. | CA | O | SVP,CHIE | 16 | S.dm | -12,343 | 45.71 | 0 | -270 | 174 | D | |||||||||||||||
10/9/24 17:39 | 10/8/24 | HALO | Health | BioPrd | Biological Products, (No Diag | Torley Helen | CA | DO | P,CEO | 7 | S.dm | -10,139 | 50.69 | 0 | -200 | 677 | D | |||||||||||||||
8/14/24 16:57 | 8/12/24 | HALO | Health | BioPrd | Biological Products, (No Diag | Posard Matthew L. | CA | D | 2 | S.m | -2,696 | 54.04 | 0 | -50 | 100 | D | ||||||||||||||||
7/23/24 16:37 | 7/22/24 | HALO | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | 2 | S.dm | -1,828 | 52.22 | 0 | -35 | 15 | D | |||||||||||||||
8/15/23 16:04 | 8/11/23 | HALO | Health | BioPrd | Biological Products, (No Diag | Daly James M | CA | D | 1 | S.m | -875 | 43.73 | 0 | -20 | 21 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |